Show simple item record

Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.

dc.contributor.authorPapier, K
dc.contributor.authorGordon, L G
dc.contributor.authorKhosrotehrani, K
dc.contributor.authorIsbel, N
dc.contributor.authorCampbell, S
dc.contributor.authorGriffin, A
dc.contributor.authorGreen, Adèle C
dc.date.accessioned2018-08-19T14:04:56Z
dc.date.available2018-08-19T14:04:56Z
dc.date.issued2018-07-13
dc.identifier.citationManagement of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland. 2018, Br J Dermatolen
dc.identifier.issn1365-2133
dc.identifier.pmid30005137
dc.identifier.doi10.1111/bjd.17001
dc.identifier.urihttp://hdl.handle.net/10541/621172
dc.description.abstractThe incidence of skin cancer in organ transplant recipients (OTRs) is very high due mainly to long-term immunosuppressive therapy. The problem is particularly severe for organ transplant recipients living in Queensland, Australia, resulting in significant mortality.
dc.language.isoenen
dc.rightsArchived with thanks to The British journal of dermatologyen
dc.titleManagement of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.en
dc.typeArticleen
dc.contributor.departmentQIMR Berghofer Medical Research Institute, Population Health Department, Brisbane, Queensland, Australiaen
dc.identifier.journalThe British Journal of Dermatologyen
refterms.dateFOA2020-04-27T11:31:47Z
html.description.abstractThe incidence of skin cancer in organ transplant recipients (OTRs) is very high due mainly to long-term immunosuppressive therapy. The problem is particularly severe for organ transplant recipients living in Queensland, Australia, resulting in significant mortality.


Files in this item

Thumbnail
Name:
560546.pdf
Size:
672.0Kb
Format:
PDF
Description:
From UNPAYWALL
Download

This item appears in the following Collection(s)

Show simple item record